BioClinica Shareholders Can't Stop $123M PE Takeover Bid

Law360, Wilmington (February 26, 2013, 12:05 AM EST) -- A Delaware state judge on Monday stymied an attempt by BioClinica Inc. shareholders to prevent its planned $123 million private equity takeover from being consummated in March, denying a request to fast-track matters in their putative class action.

BioClinica's board announced Jan. 29 that it had accepted a $7.25-per-share buyout offer from PE firm JLL Partners Inc., and investors brought multiple suits in Delaware Chancery Court seeking to hold up the transaction, which the parties expect to conclude March 11.

Vice Chancellor Sam Glasscock III credited...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.